Boehringer Ingelheim Pharmaceuticals, Inc. H-1B New Employment
Of Boehringer Ingelheim Pharmaceuticals, Inc.'s 129 certified H-1B filings with a stated employment type (FY2021–2026), 43.4% are new employment at a median of $127K/year. The rest are extensions, transfers and amendments for workers already sponsored.
Is Boehringer Ingelheim Pharmaceuticals, Inc. Hiring New H-1B Workers?
Yes. At 43.4%, Boehringer Ingelheim Pharmaceuticals, Inc. files a high share of genuinely new H-1B employment, so a meaningful part of its sponsorship goes to people it has not sponsored before. That is the population an outside applicant joins.
Employment Type Breakdown at Boehringer Ingelheim Pharmaceuticals, Inc.
Bars are scaled to this employer's largest category, not to 100%. Percentages are of Boehringer Ingelheim Pharmaceuticals, Inc.'s 129 certified filings that state an employment type. A small number of filings tick more than one box, so the shares can total slightly above 100%.
Is That Share Rising or Falling?
New-employment share per fiscal year, each against that year's filings with a stated type. Bars are scaled to this employer's peak year.
What Roles Is Boehringer Ingelheim Pharmaceuticals, Inc. Hiring Into?
Job titles on Boehringer Ingelheim Pharmaceuticals, Inc.'s new-employment filings specifically, which is what it is actually growing rather than merely maintaining.
| Role | New-Hire Filings | Median Wage |
|---|---|---|
| Biochemists and Biophysicists | 19 | $126K |
| Medical Scientists, Except Epidemiologists | 15 | $120K |
| Chemists | 4 | $103K |
| Biostatisticians | 3 | $142K |
| Chemical Engineers | 3 | $115K |
| Natural Sciences Managers | 3 | $334K |
| Bioinformatics Scientists | 2 | $136K |
| Clinical Data Managers | 2 | $124K |
Why This Number Matters
Total sponsorship volume is the figure most job boards quote, and on its own it is misleading. An employer filing thousands of petitions a year can be filing almost all of them to extend people it sponsored years ago, which tells an outside applicant very little about their odds.
The new-employment share separates the two. It is the employer's own checkbox on the Labor Condition Application, not an estimate, and it identifies the filings that represent someone entering the company rather than staying in it.
More on Boehringer Ingelheim Pharmaceuticals, Inc.
Related
Job Alert Pro
⚡ Never miss an H1B job again
Get instant email alerts for new H1B jobs matching your skills, location, and seniority level. Our system scans 130+ companies daily and notifies you before jobs fill up.
- ✓ Real-time job matching (alerts within minutes of posting)
- ✓ Verified H1B sponsors only (100% sponsorship history verified)
- ✓ Mobile app notifications (never miss a job)
- ✓ Advanced filters (location, salary, seniority, role)
- ✓ Cancel anytime (no long-term commitment)
H1B Visa Jobs Research Team
Counted from US Department of Labor LCA disclosure files (FY2021–2026) for certified petitions filed by Boehringer Ingelheim Pharmaceuticals, Inc. with annual wages between $30K and $1M, combining 3 legal-name spellings DOL records for this employer. Shares are of the 129 filings that tick at least one employment-type box; the remaining 33.8% of Boehringer Ingelheim Pharmaceuticals, Inc.'s 195 certified filings state no type and are excluded rather than counted as renewals. A certified LCA is a step toward an H-1B petition, not an approved visa.